20 studies were found.

1.		Recruiting	Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS) Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive
2.		Recruiting	Treatment of Multiple Sclerosis using Over the Counter Inosine Condition: Multiple Sclerosis, Relapsing-Remitting
3.		Recruiting	Safety and Efficacy Study of Rituximab Compared with Placebo in Adults with Primary Progressive Multiple Sclerosis Condition: Primary Progressive Multiple Sclerosis
4.		Recruiting	Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis Condition: Multiple Sclerosis, Relapsing-Remitting
5.		Recruiting	MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis Condition: Multiple Sclerosis
6.		Recruiting	Improving Memory in Patients with Multiple Sclerosis Condition: Multiple Sclerosis
7.		Recruiting	Treatment of Multiple Sclerosis with Copaxone and Albuterol Conditions: Autoimmune Diseases; Multiple Sclerosis
8.		Recruiting	Auditory Function in Patients With and Without Multiple Sclerosis Condition: Multiple Sclerosis
9.		Not yet recruiting	Induction Therapy with a Single High Dose Bolus of Intravenous Methotrexate with Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting with a First Acute Demyelinating Event. Conditions: Demyelinating Disorders; Multiple Sclerosis; Optic Neuritis; Myelitis; Neuritis
10.		Recruiting	Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis Condition: Multiple Sclerosis
11.		Recruiting	Zenapax to Treat Multiple Sclerosis Condition: Multiple Sclerosis
12.		Recruiting	Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS) Condition: Multiple Sclerosis
13.		Recruiting	Assessment of Patients with Multiple Sclerosis (MS) Conditions: Herpesviridae Infection; HTLV-I Infection; Multiple Sclerosis; Tropical Spastic Paraparesis; Vasculitis
14.		Not yet recruiting	Atorvastatin Therapy in Patients with Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis Conditions: Multiple Sclerosis; Clinically Isolated Syndrome
15.		Recruiting	Rebif® versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis Condition: Relapsing-Remitting Multiple Sclerosis
16.		Recruiting	Treating Multiple Sclerosis with Sirolimus, an Immune System Suppressor Condition: Multiple Sclerosis
17.		Recruiting	Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients with Relapsing Multiple Sclerosis (MS) Condition: Multiple Sclerosis
18.		Recruiting	Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) Conditions: Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Alzheimer's Disease; Stroke; Traumatic Brain Injury
19.		Recruiting	Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics Conditions: Chronic Disease; Healthy; Lyme Arthritis; Lyme Disease; Multiple Sclerosis
20.		Recruiting	The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients